¿Qué estás buscando? Escribe el nombre, el título o cualquier palabra clave relacionada con lo que estás buscando y selecciona a qué categoría de contenido pertenece. Buscar Fulltext search Actividades Profesionales Grupos de investigación Noticias - Cualquiera - Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv52. doi: 10.1093/annonc/mdz155.190. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz155.190 Revista ANNALS OF ONCOLOGY Títol Complet Randomized phase II clinical trial to evaluate the efficacy of second-line FOLFIRI-panitumumab in patients with RAS wild-type metastatic colorectal cancer who have received FOLFOX-panitumumab in first-line (BEYOND). Codi 47747 PMID https://pubmed.ncbi.nlm.nih.gov/32085197 Nom Autors Alvarez, R; Aparicio, J; Bosch, C; Camara, J; Capdevila, J; Fernandez-Martos, C; Fernandez-Plana, J; Gallego, J; Gallego, R; Hernandez-Yague, X et al. DOI número 10.1093/annonc/mdz155.190 Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv51-iv52. doi: 10.1093/annonc/mdz155.189. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz155.189 Revista ANNALS OF ONCOLOGY Títol Complet Update of metastatic colorectal cancer metastases resection after FOLFIRI-aflibercept in oxaliplatin-refractory patients. Codi 47746 PMID https://pubmed.ncbi.nlm.nih.gov/32085195 Nom Autors Alcaide Garcia, J; Alcaraz Nunes, D; Castanon Lopez, C; de Toro Carmena, M; Diaz Beveridge, R; Encinas Garcia, S; Fernandez Montes, A; Garcia Adrian, S; Garcia Alfonso, P; Garcia Paredes, B et al. DOI número 10.1093/annonc/mdz155.189 Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv25. doi: 10.1093/annonc/mdz155.093. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz155.093 Revista ANNALS OF ONCOLOGY Títol Complet KEYNOTE-811 pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction cancer: a double-blind, randomized, placebo-controlled phase 3 study. Codi 47745 PMID https://pubmed.ncbi.nlm.nih.gov/32085099 Nom Autors Bang, Y; Cao, Z; Chen, X; Chung, H; Fuchs, C; Janjigian, Y; Kang, S; Qin, S; Satoh, T; Shih, C et al. DOI número 10.1093/annonc/mdz155.093 Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv154. doi: 10.1093/annonc/mdz183.004. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz183.004 Revista ANNALS OF ONCOLOGY Títol Complet BEACON CRC: a randomized, 3-Arm, phase 3 study of encorafenib and cetuximab with or without binimetinib vs. choice of either irinotecan or FOLFIRI plus cetuximab in BRAF V600E-mutant metastatic colorectal cancer. Codi 47744 PMID https://pubmed.ncbi.nlm.nih.gov/32085058 Nom Autors Anderson, L; Arkenau, H; Christy-Bittel, J; Ciardiello, F; Desai, J; Garcia Alfonso, P; Gollerkeri, A; Grothey, A; Guren, T; Hong, Y et al. DOI número 10.1093/annonc/mdz183.004 Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv152-iv153. doi: 10.1093/annonc/mdz183.001. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz183.001 Revista ANNALS OF ONCOLOGY Títol Complet Pembrolizumab with or without chemotherapy versus chemotherapy for first-line treatment of advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The Phase 3 KEYNOTE-062 Study. Codi 47743 PMID https://pubmed.ncbi.nlm.nih.gov/32085055 Nom Autors Bang, Y; Braghiroli, M; Castro Salguero, H; Chao, J; Chung, H; Fuchs, C; Garrido, M; Goekkurt, E; Kang, S; Kher, U et al. DOI número 10.1093/annonc/mdz183.001 Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv152. doi: 10.1093/annonc/mdz183. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz183 Revista ANNALS OF ONCOLOGY Títol Complet Olaparib as maintenance treatment following first-line platinum-based chemotherapy in patients with a germline BRCA mutation and metastatic pancreatic cancer: phase III POLO trial. Codi 47742 PMID https://pubmed.ncbi.nlm.nih.gov/32085054 Nom Autors Algul, H; Arnold, D; Cui, K; Golan, T; Hall, M; Hammel, P; Hochhauser, D; Kindler, H; Locker, G; Macarulla, T et al. DOI número 10.1093/annonc/mdz183 Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv135. doi: 10.1093/annonc/mdz154.025. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz154.025 Revista ANNALS OF ONCOLOGY Títol Complet Results of REARRANGE trial: A randomized phase 2 study comparing different dosing approaches for regorafenib (REG) during the first cycle of treatment in patients (pts) with metastatic colorectal cancer (mCRC). Codi 47741 PMID https://pubmed.ncbi.nlm.nih.gov/32085044 Nom Autors Alfonso, P Garcia; Aranda, E; Argiles, G; Benavides, M; Bennouna, J; Cano, T; Ciardiello, F; de Prado, J Vieitez; Falcone, A; Garrote, M Rodriguez et al. DOI número 10.1093/annonc/mdz154.025 Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv127. doi: 10.1093/annonc/mdz154.004. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz154.004 Revista ANNALS OF ONCOLOGY Títol Complet Treating HER2-mutant advanced biliary tract cancer with neratinib: benefits of HER2-directed targeted therapy in the phase 2 SUMMIT 'basket' trial. Codi 47740 PMID https://pubmed.ncbi.nlm.nih.gov/32085018 Nom Autors Bernstam, F Meric; Borad, M; Brana, I; Bryce, R; Cleary, J; Cutler, R; Dujka, M; Eli, L; Harding, J; Hyman, D et al. DOI número 10.1093/annonc/mdz154.004 Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv126. doi: 10.1093/annonc/mdz154. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz154 Revista ANNALS OF ONCOLOGY Títol Complet An international, randomized, open-label, phase III trial of adjuvant nab-paclitaxel plus gemcitabine vs gemcitabine alone for surgically resected pancreatic adenocarcinoma (APACT): primary analysis and quality of life outcomes. Codi 47739 PMID https://pubmed.ncbi.nlm.nih.gov/32085016 Nom Autors Bekaii-Saab, T; Berlin, J; Biankin, A; Bruchec, Y Le; Dhani, N; Frassineti, G; Goldstein, D; Macarulla, T; Noel, M; O'Reilly, E et al. DOI número 10.1093/annonc/mdz154 Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv126. doi: 10.1093/annonc/mdz154.001. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz154.001 Revista ANNALS OF ONCOLOGY Títol Complet Ibrutinib in combination with nab-paclitaxel and gemcitabine as first-line treatment for patients with metastatic pancreatic adenocarcinoma: results from the phase 3 RESOLVE study. Codi 47738 PMID https://pubmed.ncbi.nlm.nih.gov/32085015 Nom Autors Bachet, J; Chang, H; Cole, G Jr; Coussens, L; Fong, L; Hendifar, A; James, D; Lonardi, S; Macarulla, T; Maurel, J et al. DOI número 10.1093/annonc/mdz154.001 Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv125. doi: 10.1093/annonc/mdz157.009. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz157.009 Revista ANNALS OF ONCOLOGY Títol Complet Preliminary results in colorectal cancer (CRC) patients enrolled in the GATTO study, a phase I study of Tomuzotuximab in combination with Gatipotuzumab in patients with EGFR positive solid tumors. Codi 47737 PMID https://pubmed.ncbi.nlm.nih.gov/32085014 Nom Autors Baumeister, H; Conte, G; Fiedler, W; Garralda, E; Habel, B; Kebenko, M; Klinghammer, K; Matos, I; Ochsenreither, S; Raspagliesi, F et al. DOI número 10.1093/annonc/mdz157.009 Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv123. doi: 10.1093/annonc/mdz157.004. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz157.004 Revista ANNALS OF ONCOLOGY Títol Complet A phase 1/2, open-label, dose-expansion study of liposomal irinotecan (nal-IRI) plus 5-fluorouracil/leucovorin (5-FU/LV) and oxaliplatin (OX) in patients with previously untreated metastatic pancreatic cancer. Codi 47736 PMID https://pubmed.ncbi.nlm.nih.gov/32085008 Nom Autors Belanger, B; Boland, P; Dayyani, F; Dean, A; Lieu, C; Macarulla, T; Maxwell, F; Moore, Y; Wainberg, Z; Wang, T et al. DOI número 10.1093/annonc/mdz157.004 Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv122-iv123. doi: 10.1093/annonc/mdz157.002. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz157.002 Revista ANNALS OF ONCOLOGY Títol Complet Debio 1347 in patients with gastrointestinal cancers harboring an FGFR gene fusion: preliminary results. Codi 47735 PMID https://pubmed.ncbi.nlm.nih.gov/32085006 Nom Autors Bernstam, F Meric; Chessex, A Vaslin; Cleary, J; Flaherty, K; Goyal, L; Hu, Y; Hyman, D; Ishii, N; Iyer, G; Kirpicheva, Y et al. DOI número 10.1093/annonc/mdz157.002 Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv117. doi: 10.1093/annonc/mdz156.023. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz156.023 Revista ANNALS OF ONCOLOGY Títol Complet Exploratory analysis of the effect of FTD/TPI in mCRC patients treated in RECOURSE by different prognostic factors: impact on ECOG PS. Codi 47734 PMID https://pubmed.ncbi.nlm.nih.gov/32084991 Nom Autors Argiles, G; Mayer, R; Moreno Vera, S; Ohtsu, A; Sobrero, A; Tabernero, J; Van Cutsem, E; Vidot, L et al. DOI número 10.1093/annonc/mdz156.023 Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv110. doi: 10.1093/annonc/mdz156. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz156 Revista ANNALS OF ONCOLOGY Títol Complet Analysis of patient screening in the phase III, international, randomized, open-label APACT trial. Codi 47733 PMID https://pubmed.ncbi.nlm.nih.gov/32084969 Nom Autors Bendell, J; Berlin, J; Chang, H; Diaz, I Ales; Garlipp, B; Goldstein, D; Jeanes, J; Lu, B; Macarulla, T; Milella, M et al. DOI número 10.1093/annonc/mdz156 Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv109. doi: 10.1093/annonc/mdz155.399. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz155.399 Revista ANNALS OF ONCOLOGY Títol Complet ANCHOR CRC: a phase 2, open-label, single arm, multicenter study of encorafenib (ENCO), binimetinib (BINI), plus cetuximab (CETUX) in patients with previously untreated BRAF V600E-mutant metastatic colorectal cancer (mCRC). Codi 47732 PMID https://pubmed.ncbi.nlm.nih.gov/32084963 Nom Autors Chetaille, E; Groc, M; Grothey, A; Paez, D; Tabernero, J; Taieb, J; Van Cutsem, E; Vedovato, J; Yaeger, R; Yoshino, T et al. DOI número 10.1093/annonc/mdz155.399 Year 2019 Tipus publicació Revisión en revista internacional DOI http://dx.doi.org/10.1007/978-3-030-02278-5_41 Títol Complet Graft Failure Codi 47731 PMID https://pubmed.ncbi.nlm.nih.gov/32091792 Nom Autors Sureda, Anna; Valcarcel, David et al. DOI número 10.1007/978-3-030-02278-5_41 Year 2019 Tipus publicació Revisión en revista internacional DOI http://dx.doi.org/10.1007/978-3-030-02278-5_78 Títol Complet Fanconi's Anemia and Other Hereditary Bone Marrow Failure Syndromes Autors Maria Cristina Díaz de Heredia Rubio Codi 47730 PMID https://pubmed.ncbi.nlm.nih.gov/32091782 Nom Autors Bierings, Marc; Dalle, Jean-Hugues; Diaz de Heredia, Cristina; Fioredda, Francesca; Strahm, Brigitte et al. DOI número 10.1007/978-3-030-02278-5_78 Year 2019 Referencia Transplant Direct. 2019 Nov 18;5(12):e510. doi: 10.1097/TXD.0000000000000954. eCollection 2019 Dec. Tipus publicació Artículo en revista internacional DOI http://dx.doi.org/10.1097/TXD.0000000000000954 Revista Transplantation direct Títol Complet Direct-acting Antivirals for the Treatment of Kidney Transplant Patients With Chronic Hepatitis C Virus Infection in Spain: A Long-term Prospective Observational Study. Autors Manel Perelló Carrascosa Codi 47729 PMID https://pubmed.ncbi.nlm.nih.gov/32095505 Nom Autors Alonso, Angel; Beneyto, Isabel; Crespo, Marta; de Gracia Guindo, Maria Del Carmen; Diaz-Corte, Carmen; Franco, Antonio; Gentil, Miguel Angel; Gonzalez-Corvillo, Carmen; Guirado, Luis; Hernandez, Domingo et al. DOI número 10.1097/TXD.0000000000000954 Year 2019 Referencia Nephrol Dial Transplant. 2019 Aug 1;34(8):1369-1377. doi: 10.1093/ndt/gfy165. Tipus publicació Artículo en revista internacional DOI http://dx.doi.org/10.1093/ndt/gfy165 Revista NEPHROLOGY DIALYSIS TRANSPLANTATION Títol Complet Management of children with congenital nephrotic syndrome: challenging treatment paradigms. Autors Gema Ariceta Iraola Codi 47728 PMID https://pubmed.ncbi.nlm.nih.gov/30215773 Nom Autors Alpay, Harika; Ariceta, Gema; Aufricht, Christoph; Bacchetta, Justine; Bakkaloglu, Sevcan A; Bayazit, Aysun; Bockenhauer, Detlef; Cicek, Rumeysa Yasemin; do Sameiro Faria, Maria; Dufek, Stephanie et al. DOI número 10.1093/ndt/gfy165 Paginación Primera página « Página anterior ‹ … Página 2132 Página 2133 Página actual 2134 Página 2135 Página 2136 … Siguiente página › Última página »
Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv52. doi: 10.1093/annonc/mdz155.190. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz155.190 Revista ANNALS OF ONCOLOGY Títol Complet Randomized phase II clinical trial to evaluate the efficacy of second-line FOLFIRI-panitumumab in patients with RAS wild-type metastatic colorectal cancer who have received FOLFOX-panitumumab in first-line (BEYOND). Codi 47747 PMID https://pubmed.ncbi.nlm.nih.gov/32085197 Nom Autors Alvarez, R; Aparicio, J; Bosch, C; Camara, J; Capdevila, J; Fernandez-Martos, C; Fernandez-Plana, J; Gallego, J; Gallego, R; Hernandez-Yague, X et al. DOI número 10.1093/annonc/mdz155.190
Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv51-iv52. doi: 10.1093/annonc/mdz155.189. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz155.189 Revista ANNALS OF ONCOLOGY Títol Complet Update of metastatic colorectal cancer metastases resection after FOLFIRI-aflibercept in oxaliplatin-refractory patients. Codi 47746 PMID https://pubmed.ncbi.nlm.nih.gov/32085195 Nom Autors Alcaide Garcia, J; Alcaraz Nunes, D; Castanon Lopez, C; de Toro Carmena, M; Diaz Beveridge, R; Encinas Garcia, S; Fernandez Montes, A; Garcia Adrian, S; Garcia Alfonso, P; Garcia Paredes, B et al. DOI número 10.1093/annonc/mdz155.189
Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv25. doi: 10.1093/annonc/mdz155.093. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz155.093 Revista ANNALS OF ONCOLOGY Títol Complet KEYNOTE-811 pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction cancer: a double-blind, randomized, placebo-controlled phase 3 study. Codi 47745 PMID https://pubmed.ncbi.nlm.nih.gov/32085099 Nom Autors Bang, Y; Cao, Z; Chen, X; Chung, H; Fuchs, C; Janjigian, Y; Kang, S; Qin, S; Satoh, T; Shih, C et al. DOI número 10.1093/annonc/mdz155.093
Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv154. doi: 10.1093/annonc/mdz183.004. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz183.004 Revista ANNALS OF ONCOLOGY Títol Complet BEACON CRC: a randomized, 3-Arm, phase 3 study of encorafenib and cetuximab with or without binimetinib vs. choice of either irinotecan or FOLFIRI plus cetuximab in BRAF V600E-mutant metastatic colorectal cancer. Codi 47744 PMID https://pubmed.ncbi.nlm.nih.gov/32085058 Nom Autors Anderson, L; Arkenau, H; Christy-Bittel, J; Ciardiello, F; Desai, J; Garcia Alfonso, P; Gollerkeri, A; Grothey, A; Guren, T; Hong, Y et al. DOI número 10.1093/annonc/mdz183.004
Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv152-iv153. doi: 10.1093/annonc/mdz183.001. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz183.001 Revista ANNALS OF ONCOLOGY Títol Complet Pembrolizumab with or without chemotherapy versus chemotherapy for first-line treatment of advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The Phase 3 KEYNOTE-062 Study. Codi 47743 PMID https://pubmed.ncbi.nlm.nih.gov/32085055 Nom Autors Bang, Y; Braghiroli, M; Castro Salguero, H; Chao, J; Chung, H; Fuchs, C; Garrido, M; Goekkurt, E; Kang, S; Kher, U et al. DOI número 10.1093/annonc/mdz183.001
Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv152. doi: 10.1093/annonc/mdz183. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz183 Revista ANNALS OF ONCOLOGY Títol Complet Olaparib as maintenance treatment following first-line platinum-based chemotherapy in patients with a germline BRCA mutation and metastatic pancreatic cancer: phase III POLO trial. Codi 47742 PMID https://pubmed.ncbi.nlm.nih.gov/32085054 Nom Autors Algul, H; Arnold, D; Cui, K; Golan, T; Hall, M; Hammel, P; Hochhauser, D; Kindler, H; Locker, G; Macarulla, T et al. DOI número 10.1093/annonc/mdz183
Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv135. doi: 10.1093/annonc/mdz154.025. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz154.025 Revista ANNALS OF ONCOLOGY Títol Complet Results of REARRANGE trial: A randomized phase 2 study comparing different dosing approaches for regorafenib (REG) during the first cycle of treatment in patients (pts) with metastatic colorectal cancer (mCRC). Codi 47741 PMID https://pubmed.ncbi.nlm.nih.gov/32085044 Nom Autors Alfonso, P Garcia; Aranda, E; Argiles, G; Benavides, M; Bennouna, J; Cano, T; Ciardiello, F; de Prado, J Vieitez; Falcone, A; Garrote, M Rodriguez et al. DOI número 10.1093/annonc/mdz154.025
Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv127. doi: 10.1093/annonc/mdz154.004. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz154.004 Revista ANNALS OF ONCOLOGY Títol Complet Treating HER2-mutant advanced biliary tract cancer with neratinib: benefits of HER2-directed targeted therapy in the phase 2 SUMMIT 'basket' trial. Codi 47740 PMID https://pubmed.ncbi.nlm.nih.gov/32085018 Nom Autors Bernstam, F Meric; Borad, M; Brana, I; Bryce, R; Cleary, J; Cutler, R; Dujka, M; Eli, L; Harding, J; Hyman, D et al. DOI número 10.1093/annonc/mdz154.004
Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv126. doi: 10.1093/annonc/mdz154. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz154 Revista ANNALS OF ONCOLOGY Títol Complet An international, randomized, open-label, phase III trial of adjuvant nab-paclitaxel plus gemcitabine vs gemcitabine alone for surgically resected pancreatic adenocarcinoma (APACT): primary analysis and quality of life outcomes. Codi 47739 PMID https://pubmed.ncbi.nlm.nih.gov/32085016 Nom Autors Bekaii-Saab, T; Berlin, J; Biankin, A; Bruchec, Y Le; Dhani, N; Frassineti, G; Goldstein, D; Macarulla, T; Noel, M; O'Reilly, E et al. DOI número 10.1093/annonc/mdz154
Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv126. doi: 10.1093/annonc/mdz154.001. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz154.001 Revista ANNALS OF ONCOLOGY Títol Complet Ibrutinib in combination with nab-paclitaxel and gemcitabine as first-line treatment for patients with metastatic pancreatic adenocarcinoma: results from the phase 3 RESOLVE study. Codi 47738 PMID https://pubmed.ncbi.nlm.nih.gov/32085015 Nom Autors Bachet, J; Chang, H; Cole, G Jr; Coussens, L; Fong, L; Hendifar, A; James, D; Lonardi, S; Macarulla, T; Maurel, J et al. DOI número 10.1093/annonc/mdz154.001
Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv125. doi: 10.1093/annonc/mdz157.009. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz157.009 Revista ANNALS OF ONCOLOGY Títol Complet Preliminary results in colorectal cancer (CRC) patients enrolled in the GATTO study, a phase I study of Tomuzotuximab in combination with Gatipotuzumab in patients with EGFR positive solid tumors. Codi 47737 PMID https://pubmed.ncbi.nlm.nih.gov/32085014 Nom Autors Baumeister, H; Conte, G; Fiedler, W; Garralda, E; Habel, B; Kebenko, M; Klinghammer, K; Matos, I; Ochsenreither, S; Raspagliesi, F et al. DOI número 10.1093/annonc/mdz157.009
Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv123. doi: 10.1093/annonc/mdz157.004. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz157.004 Revista ANNALS OF ONCOLOGY Títol Complet A phase 1/2, open-label, dose-expansion study of liposomal irinotecan (nal-IRI) plus 5-fluorouracil/leucovorin (5-FU/LV) and oxaliplatin (OX) in patients with previously untreated metastatic pancreatic cancer. Codi 47736 PMID https://pubmed.ncbi.nlm.nih.gov/32085008 Nom Autors Belanger, B; Boland, P; Dayyani, F; Dean, A; Lieu, C; Macarulla, T; Maxwell, F; Moore, Y; Wainberg, Z; Wang, T et al. DOI número 10.1093/annonc/mdz157.004
Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv122-iv123. doi: 10.1093/annonc/mdz157.002. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz157.002 Revista ANNALS OF ONCOLOGY Títol Complet Debio 1347 in patients with gastrointestinal cancers harboring an FGFR gene fusion: preliminary results. Codi 47735 PMID https://pubmed.ncbi.nlm.nih.gov/32085006 Nom Autors Bernstam, F Meric; Chessex, A Vaslin; Cleary, J; Flaherty, K; Goyal, L; Hu, Y; Hyman, D; Ishii, N; Iyer, G; Kirpicheva, Y et al. DOI número 10.1093/annonc/mdz157.002
Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv117. doi: 10.1093/annonc/mdz156.023. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz156.023 Revista ANNALS OF ONCOLOGY Títol Complet Exploratory analysis of the effect of FTD/TPI in mCRC patients treated in RECOURSE by different prognostic factors: impact on ECOG PS. Codi 47734 PMID https://pubmed.ncbi.nlm.nih.gov/32084991 Nom Autors Argiles, G; Mayer, R; Moreno Vera, S; Ohtsu, A; Sobrero, A; Tabernero, J; Van Cutsem, E; Vidot, L et al. DOI número 10.1093/annonc/mdz156.023
Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv110. doi: 10.1093/annonc/mdz156. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz156 Revista ANNALS OF ONCOLOGY Títol Complet Analysis of patient screening in the phase III, international, randomized, open-label APACT trial. Codi 47733 PMID https://pubmed.ncbi.nlm.nih.gov/32084969 Nom Autors Bendell, J; Berlin, J; Chang, H; Diaz, I Ales; Garlipp, B; Goldstein, D; Jeanes, J; Lu, B; Macarulla, T; Milella, M et al. DOI número 10.1093/annonc/mdz156
Year 2019 Referencia Ann Oncol. 2019 Jul;30 Suppl 4:iv109. doi: 10.1093/annonc/mdz155.399. Epub 2019 Dec 4. Tipus publicació Carta o abstract DOI http://dx.doi.org/10.1093/annonc/mdz155.399 Revista ANNALS OF ONCOLOGY Títol Complet ANCHOR CRC: a phase 2, open-label, single arm, multicenter study of encorafenib (ENCO), binimetinib (BINI), plus cetuximab (CETUX) in patients with previously untreated BRAF V600E-mutant metastatic colorectal cancer (mCRC). Codi 47732 PMID https://pubmed.ncbi.nlm.nih.gov/32084963 Nom Autors Chetaille, E; Groc, M; Grothey, A; Paez, D; Tabernero, J; Taieb, J; Van Cutsem, E; Vedovato, J; Yaeger, R; Yoshino, T et al. DOI número 10.1093/annonc/mdz155.399
Year 2019 Tipus publicació Revisión en revista internacional DOI http://dx.doi.org/10.1007/978-3-030-02278-5_41 Títol Complet Graft Failure Codi 47731 PMID https://pubmed.ncbi.nlm.nih.gov/32091792 Nom Autors Sureda, Anna; Valcarcel, David et al. DOI número 10.1007/978-3-030-02278-5_41
Year 2019 Tipus publicació Revisión en revista internacional DOI http://dx.doi.org/10.1007/978-3-030-02278-5_78 Títol Complet Fanconi's Anemia and Other Hereditary Bone Marrow Failure Syndromes Autors Maria Cristina Díaz de Heredia Rubio Codi 47730 PMID https://pubmed.ncbi.nlm.nih.gov/32091782 Nom Autors Bierings, Marc; Dalle, Jean-Hugues; Diaz de Heredia, Cristina; Fioredda, Francesca; Strahm, Brigitte et al. DOI número 10.1007/978-3-030-02278-5_78
Year 2019 Referencia Transplant Direct. 2019 Nov 18;5(12):e510. doi: 10.1097/TXD.0000000000000954. eCollection 2019 Dec. Tipus publicació Artículo en revista internacional DOI http://dx.doi.org/10.1097/TXD.0000000000000954 Revista Transplantation direct Títol Complet Direct-acting Antivirals for the Treatment of Kidney Transplant Patients With Chronic Hepatitis C Virus Infection in Spain: A Long-term Prospective Observational Study. Autors Manel Perelló Carrascosa Codi 47729 PMID https://pubmed.ncbi.nlm.nih.gov/32095505 Nom Autors Alonso, Angel; Beneyto, Isabel; Crespo, Marta; de Gracia Guindo, Maria Del Carmen; Diaz-Corte, Carmen; Franco, Antonio; Gentil, Miguel Angel; Gonzalez-Corvillo, Carmen; Guirado, Luis; Hernandez, Domingo et al. DOI número 10.1097/TXD.0000000000000954
Year 2019 Referencia Nephrol Dial Transplant. 2019 Aug 1;34(8):1369-1377. doi: 10.1093/ndt/gfy165. Tipus publicació Artículo en revista internacional DOI http://dx.doi.org/10.1093/ndt/gfy165 Revista NEPHROLOGY DIALYSIS TRANSPLANTATION Títol Complet Management of children with congenital nephrotic syndrome: challenging treatment paradigms. Autors Gema Ariceta Iraola Codi 47728 PMID https://pubmed.ncbi.nlm.nih.gov/30215773 Nom Autors Alpay, Harika; Ariceta, Gema; Aufricht, Christoph; Bacchetta, Justine; Bakkaloglu, Sevcan A; Bayazit, Aysun; Bockenhauer, Detlef; Cicek, Rumeysa Yasemin; do Sameiro Faria, Maria; Dufek, Stephanie et al. DOI número 10.1093/ndt/gfy165
